Evolent Health (EVH) Depreciation and Depletion (2015 - 2026)

Evolent Health's Depreciation and Depletion history runs 12 years deep, the most recent figure standing at $6.3 million for Q1 2026.

• On a quarterly basis, Depreciation and Depletion fell 13.7% year-over-year to $6.3 million in Q1 2026; TTM through Mar 2026 was $25.3 million, a 15.95% decrease from a year earlier, with the FY2025 full-year figure at $26.3 million, down 13.2% from the prior year.
• Depreciation and Depletion was little changed at $6.3 million in Q1 2026 per EVH's latest filing, from $6.3 million in the prior quarter.
• Across five years, Depreciation and Depletion topped out at $8.9 million in Q4 2022 and bottomed at $6.3 million in Q3 2025.
• The 5-year median for Depreciation and Depletion is $7.6 million (2022), against an average of $7.5 million.
• Across the five-year window, Depreciation and Depletion grew 14.1% in 2022 and fell 18.99% in 2025, its largest moves.
• Year by year, Depreciation and Depletion stood at $8.9 million in 2022, then retreated by 14.61% to $7.6 million in 2023, then retreated by 2.63% to $7.4 million in 2024, then decreased by 14.86% to $6.3 million in 2025, then changed by 0.0% to $6.3 million in 2026.
• Per Business Quant, the three latest EVH Depreciation and Depletion figures stand at $6.3 million (Q1 2026), $6.3 million (Q4 2025), and $6.3 million (Q3 2025).